Medicare GLP-1 Clinics in New York
Browse GLP-1 clinics in New York that accept Medicare. Compare providers, check medication availability, and book a consultation.
Cities With Medicare GLP-1 Clinics
GLP-1 Clinics Accepting Medicare in New York
Manhattan Medical Arts - W 13th St Union Square
LifeMD
Medicare GLP-1 Coverage Details
Coverage Overview
Medicare coverage for GLP-1 medications has been evolving rapidly. Medicare Part D covers GLP-1 medications prescribed for type 2 diabetes (Ozempic, Mounjaro). The landmark expansion of Medicare to cover anti-obesity medications has been a major development in 2025-2026, with Wegovy and Zepbound becoming available under certain Part D plans.
Medication Coverage
| Medication | Status | Notes |
|---|---|---|
| Ozempic (semaglutide) | Covered | Covered for type 2 diabetes under Medicare Part D. Subject to plan-specific formulary placement and cost-sharing. Not covered for off-label weight loss. |
| Wegovy (semaglutide) | Varies | FDA-approved for weight management. Medicare coverage expanding through legislative and CMS policy changes. Check your specific Part D plan for current status. |
| Mounjaro (tirzepatide) | Covered | Covered for type 2 diabetes. Strong formulary position across most Part D plans. |
| Zepbound (tirzepatide) | Varies | FDA-approved for weight management. Coverage under Medicare is expanding. Check your specific Part D plan. |
Cost Estimates
Savings tip: The Inflation Reduction Act capped out-of-pocket Part D costs at $2,000/year starting in 2025. This significantly reduces the annual cost burden for expensive GLP-1 medications. Extra Help (Low Income Subsidy) can further reduce costs.
Medicare GLP-1 FAQ for New York
There are 3 GLP-1 clinics in New York that have reported accepting Medicare insurance. Out of 79 total clinics in the state, these providers can help you access GLP-1 medications with your Medicare plan.
Medicare generally covers GLP-1 medications like Ozempic and Mounjaro for type 2 diabetes across all states including New York. Coverage for weight management medications (Wegovy, Zepbound) varies by plan. Contact Medicare directly or check your plan documents for specific coverage details.
Your prescribing doctor in New York submits a prior authorization request to Medicare with your diagnosis, BMI, and treatment history. Processing typically takes 2-10 business days. Ask your clinic to submit the request proactively to avoid delays.
You have the right to appeal any denial. Ask your doctor to submit a peer-to-peer review or formal appeal with additional clinical documentation. Many initial denials are overturned on appeal. New York insurance regulations may provide additional appeal protections.